| DNA evidence requires an ever-increasing profile in investigations. Any type of
organism can be identified by examination of the DNA sequences unique to that
species. However, identifying individuals within a species is less precise,
although as DNA sequencing technology progresses, direct comparison of very
large DNA segments, and possibly even whole genomes, will become feasible and
practical and will allow precise individual identification. Numerous
applications include identifying suspects whose DNA matches evidence left at
crime scenes, exonerating persons wrongly accused of crimes, identifying crime
and catastrophe victims, establishing paternity and family relationships,
identifying endangered and protected species, detecting microorganisms,
determining pedigrees for seed or livestock breeds, and authenticating
consumables. The goal of this program is to provide an integrated examination of
evidence available from DNA - the prospects for further enhancements in
technology, databases, and procedures to address the issues of current
controversy. When used to its full potential, DNA evidence will help solve and
may even prevent crime. Investigative professionals will uncover a wealth of
valuable information to enable their case examinations and to eliminate their
backlogs.
Scientific Advisors
Dr. Bruce Budowle, FBI
Dr. Robin W. Cotton, Orchid Cellmark
Dr. James Robertson, FBI
Dr. James Schumm, Bode Technology Group
Speakers
Microbial Forensics
Dr. Randall Murch, Institute for Defense Analyses
Mr. Mark Wilson, FBI Laboratory
Dr. Paul Keim, Northern Arizona University
Dr. Kathleen Hickman, DTRA
Dr. Terry Leighton, Children’s Hospital Oakland Research Institute
Dr. J. Eugene LeClerc, FDA
Special Invitation:
Complimentary Invitation to Attend the Small Chips for Small Genomes Session
Where: Taking place at the Nucleic Acid-Based Technologies Conference
When: June 23, 2004, 2:00pm - 5:00pm |
Databases
Ms. Lisa Kreeger, American Prosecutors Research Institute
Mr. Charles Barna, Michigan State Police
Mr. Jason Gilder, Systems Engineer, Forensic Bioinformatics, Inc.
Dr. Kumar Hari, Ibis Therapeutics, a division of Isis Pharmaceuticals
Dr. Heather Miller Coyle, Connecticut State Police Forensic Laboratory
Dr. Marc Allard, George Washington University
Creating a Higher Throughput Laboratory
Dr. Thomas Scholl, Myriad Genetics, Inc.
Dr. Stephen Sherry, NCBI/NIH
Dr. James W. Schumm, The Bode Technology Group
Dr. Alex M. Garvin, Bureco, AG
Mrs. Gabriela Saldanha, Promega Corporation
Mr. Mark Kavlick, FBI
Dr. Phillip Danielson, University of Denver
Dr. Zach Gaskin, DNAPrint Genomics, Inc.
For sponsorship or exhibiting
information, please contact:
Angela Parsons at 781-972-5467 or aparsons@healthtech.com
|
